Summary

HNY Research projects that the Veterinary Vaccine Adjuvants market size will grow from 353.22 Million USD in 2025 to 565.25 Million USD by 2031, at an estimated CAGR of 8.15%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 78.77 Million USD, the Europe market size was 66.62 Million USD, and the Asia market size was 88.09 Million USD.
This report presents a detailed and holistic analysis of the global Veterinary Vaccine Adjuvants market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Veterinary Vaccine Adjuvants manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
SEPPIC
SDA BIO
Croda
SPI Pharma
Phibro Animal Health
Vertellus

By Type
Emulsion Adjuvants
Mineral Adjuvants
Others

By Application
Livestock Vaccines
Companion Animals Vaccines

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Veterinary Vaccine Adjuvants Revenue
1.4 Market Analysis by Type
1.4.1 Global Veterinary Vaccine Adjuvants Market Size Growth Rate by Type: 2026-2031
1.4.2 Emulsion Adjuvants
1.4.3 Mineral Adjuvants
1.4.4 Others
1.5 Market by Application
1.5.1 Global Veterinary Vaccine Adjuvants Market Share by Application: 2026-2031
1.5.2 Livestock Vaccines
1.5.3 Companion Animals Vaccines
1.6 Study Objectives
1.7 Overview of Global Veterinary Vaccine Adjuvants Market
1.7.1 Global Veterinary Vaccine Adjuvants Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Veterinary Vaccine Adjuvants
2.2 Industry Chain Structure of Veterinary Vaccine Adjuvants
3 Market Competition by Manufacturers
3.1 Global Veterinary Vaccine Adjuvants Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Veterinary Vaccine Adjuvants Average Price by Manufacturers (2020-2025)
4 Veterinary Vaccine Adjuvants Regional Market Analysis
4.1 Veterinary Vaccine Adjuvants Production by Regions
4.1.1 Global Veterinary Vaccine Adjuvants Production by Regions (2020-2025)
4.1.2 Global Veterinary Vaccine Adjuvants Revenue by Regions
4.2 Veterinary Vaccine Adjuvants Consumption by Regions
4.3 North America Veterinary Vaccine Adjuvants Market Analysis
4.3.1 North America Veterinary Vaccine Adjuvants Production
4.3.2 North America Veterinary Vaccine Adjuvants Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Veterinary Vaccine Adjuvants Import and Export
4.4 East Asia Veterinary Vaccine Adjuvants Market Analysis
4.4.1 East Asia Veterinary Vaccine Adjuvants Production
4.4.2 East Asia Veterinary Vaccine Adjuvants Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Veterinary Vaccine Adjuvants Import & Export
4.5 Europe Veterinary Vaccine Adjuvants Market Analysis
4.5.1 Europe Veterinary Vaccine Adjuvants Production
4.5.2 Europe Veterinary Vaccine Adjuvants Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Veterinary Vaccine Adjuvants Import & Export
4.6 South Asia Veterinary Vaccine Adjuvants Market Analysis
4.6.1 South Asia Veterinary Vaccine Adjuvants Production
4.6.2 South Asia Veterinary Vaccine Adjuvants Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Veterinary Vaccine Adjuvants Import & Export
4.7 Southeast Asia Veterinary Vaccine Adjuvants Market Analysis
4.7.1 Southeast Asia Veterinary Vaccine Adjuvants Production
4.7.2 Southeast Asia Veterinary Vaccine Adjuvants Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Veterinary Vaccine Adjuvants Import & Export
4.8 Middle East Veterinary Vaccine Adjuvants Market Analysis
4.8.1 Middle East Veterinary Vaccine Adjuvants Production
4.8.2 Middle East Veterinary Vaccine Adjuvants Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Veterinary Vaccine Adjuvants Import & Export
4.9 Africa Veterinary Vaccine Adjuvants Market Analysis
4.9.1 Africa Veterinary Vaccine Adjuvants Production
4.9.2 Africa Veterinary Vaccine Adjuvants Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Veterinary Vaccine Adjuvants Import & Export
4.10 Oceania Veterinary Vaccine Adjuvants Market Analysis
4.10.1 Oceania Veterinary Vaccine Adjuvants Production
4.10.2 Oceania Veterinary Vaccine Adjuvants Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Veterinary Vaccine Adjuvants Import & Export
4.11 South America Veterinary Vaccine Adjuvants Market Analysis
4.11.1 South America Veterinary Vaccine Adjuvants Production
4.11.2 South America Veterinary Vaccine Adjuvants Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Veterinary Vaccine Adjuvants Import & Export
5 Veterinary Vaccine Adjuvants Sales Market by Type (2020-2031)
5.1 Global Veterinary Vaccine Adjuvants Historic Market Size by Type (2020-2025)
5.2 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Type (2026-2031)
6 Veterinary Vaccine Adjuvants Consumption Market by Application(2020-2031)
6.1 Global Veterinary Vaccine Adjuvants Historic Market Size by Application (2020-2025)
6.2 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Veterinary Vaccine Adjuvants Business
7.1 SEPPIC
7.1.1 SEPPIC Company Profile
7.1.2 SEPPIC Veterinary Vaccine Adjuvants Product Specification
7.1.3 SEPPIC Veterinary Vaccine Adjuvants Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 SDA BIO
7.2.1 SDA BIO Company Profile
7.2.2 SDA BIO Veterinary Vaccine Adjuvants Product Specification
7.2.3 SDA BIO Veterinary Vaccine Adjuvants Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Croda
7.3.1 Croda Company Profile
7.3.2 Croda Veterinary Vaccine Adjuvants Product Specification
7.3.3 Croda Veterinary Vaccine Adjuvants Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 SPI Pharma
7.4.1 SPI Pharma Company Profile
7.4.2 SPI Pharma Veterinary Vaccine Adjuvants Product Specification
7.4.3 SPI Pharma Veterinary Vaccine Adjuvants Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Phibro Animal Health
7.5.1 Phibro Animal Health Company Profile
7.5.2 Phibro Animal Health Veterinary Vaccine Adjuvants Product Specification
7.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Vertellus
7.6.1 Vertellus Company Profile
7.6.2 Vertellus Veterinary Vaccine Adjuvants Product Specification
7.6.3 Vertellus Veterinary Vaccine Adjuvants Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Veterinary Vaccine Adjuvants (2026-2031)
8.2 Global Forecasted Revenue of Veterinary Vaccine Adjuvants (2026-2031)
8.3 Global Forecasted Price of Veterinary Vaccine Adjuvants (2020-2031)
8.4 Global Forecasted Production of Veterinary Vaccine Adjuvants by Region (2026-2031)
8.4.1 North America Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.3 Europe Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.7 Africa Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.9 South America Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Veterinary Vaccine Adjuvants Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Veterinary Vaccine Adjuvants by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.2 East Asia Market Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.3 Europe Market Forecasted Consumption of Veterinary Vaccine Adjuvants by Countriy
9.4 South Asia Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.5 Southeast Asia Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.6 Middle East Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.7 Africa Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.8 Oceania Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.9 South America Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
9.10 Rest of the world Forecasted Consumption of Veterinary Vaccine Adjuvants by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer